Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $26.4M (162,232 shares) of Procter & Gamble on Feb 12, 2026. Filing
- Last sale before this period: Oct 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Procter & Gamble (PG) | Retired Chairman | Jan 9, 2009 | Aug 10, 2026 |
| Eli Lilly (LLY) | Director | Dec 4, 2024 | Nov 18, 2025 |
Also a director at
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 12, 2026, Procter & Gamble: sold 162,232 shares for $26.4M, no plan disclosed; 162,232 shares acquired by exercising options. 1 filing: 1
- Feb 11, 2026, Procter & Gamble: sold 11,036 shares for $1.8M, no plan disclosed; 11,036 shares acquired by exercising options. 1 filing: 1
- Dec 3, 2025, Procter & Gamble: 1,029 shares withheld by the company for taxes; 159 shares vested. 1 filing: 1
- Nov 17, 2025, Eli Lilly: 233 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.